The James Buchanan Brady Urological Institute
 
Overview Basic anatomy Signs & Symptoms Screening and diagnosis Treatments Clinical Trials People Bladder Cancer Research
Center
Screening and Detection New Drug Development
& Treatment for superficial
Bladder Cancer
Surgical Innovation in
Management of Invasive
Bladder Cancer
Exploring Treatment for
Bladder Cancer
Bladder Preserving Therapies Symptom Management
and Quality of Life Issues
Books/Articles Audio/Video Resources Related Links Meeting Tracker
   BLADDER CANCER              Cystectomy Information Binder
bladder cancer
NPR's Diane Rehm Show featured a one hour show about bladder cancer.
bladder cancer patient
Patient Steve Winick talks about his bladder cancer treatment at Johns Hopkins
bladder cancer
TNG-CL009 Autologous Neo-Urinary Conduit Clinical Trial


SURGICAL INNOVATION IN MANAGEMENT OF INVASIVE BLADDER CANCER

"Nerve sparing" cystoprostatectomy
Neobladder bladder reconstruction

Surgical treatment of patients with genitourinary malignancies remains a paramount interest of the faculty and staff of the Brady Urological Institute; and that interest extends importantly to patients with all forms of bladder cancer.

Discoveries by Dr. Patrick C.Walsh defined the location of nerves that are responsible for potency in men. Years of surgical research and anatomic studies of the location of these nerves have allowed for the development of a highly emulated technique for "nerve sparing" removal in the male (complete cystoprostatectomy) to permit preservation of potency in patients undergoing major surgery for bladder cancer.

 


 

 



Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function.
J Urol. 1987 Dec;138(6):1402-6.

The disease-specific survival of men undergoing this types of surgery as well as data on potency after the operation appear below:


Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup.
J Urol. 1996 Feb; 155(2):490-4.


Post-operative potency status of 78 evaluable patients listed by pathological stage and age group at time of surgery (no.potent/no.evaluable)

Stage 20-29
years
30-39 40-49 50-59 60-69 70-79 Totals
PO - - 2/2 5/7 2/5 - 9/14      64%
PA - - 1/3 - - 1/3 2/6      33%
PIS - - 0/1 2/5 3/10 0/1 5/17      22%
P1 - - 2/3 1/4 2/6 - 5/13      30%
P2 - - 2/2 1/2 1/1 - 4/5      80%
P3A 1/1 - 1/2 1/1 0/1 0/1 2/5      40%
P3B - - 0/3 1/4 2/5 1/4 5/17      29%
P4 - - - 1/1 - - 1/1      100%
Totals 1/1
100%
- 8/16
50%
12/14
50%
11/31
35%
1/6
17%
 

The surgical intervention for invasive bladder cancer is routine and well organized at Johns Hopkins. Complete preoperative consultation, imaging, endoscopic evaluation and expert review of biopsy material and laboratory and x-ray data are accomplished by the faculty and staff of the Institute. All forms of urinary tract reconstruction including ileal-conduit, continent catheterizable and orthoptic neobladder reconstruction are routinely performed at Johns Hopkins.



© Copyright 2011 | All Rights Reserved | Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287